1. Adibhatla RM, Hatcher JF. Altered lipid metabolism in brain injury and disorders. Subcell. Biochem. 2008;49:241–268. [PMC free article] [PubMed] [Google Scholar]
2. Afa*ghi A, O'Connor H, Chow CM. Acute effects of the very low carbohydrate diet on sleep indices. Nutr. Neurosci. 2008;11:146–154. [PubMed] [Google Scholar]
3. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia. 2006;47:867–872. [PubMed] [Google Scholar]
4. Auestad N, Korsak RA, Morrow JW, Edmond J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J. Neurochem. 1991;56:1376–1386. [PubMed] [Google Scholar]
5. Baborka CJ. Epilepsy in adults: results of treatment by ketogenic diet in one hundred cases. Arch. Neurol. 1930;6:904–914. [Google Scholar]
6. Balietti M, Giorgetti B, Fattoretti P, Grossi Y, Di Stefano G, Casoli T, Platano D, Solazzi M, Orlando F, Aicardi G, Bertoni-Freddari C. Ketogenic diets cause opposing changes in synaptic morphology in CA1 hippocampus and dentate gyrus of late-adult rats. Rejuvenation Res. 2008;11:631–640. [PubMed] [Google Scholar]
7. Barañano KW, Hartman AL. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr. Treat. Options Neurol. 2008;10:410–419. [PMC free article] [PubMed] [Google Scholar]
8. Basheer R, Strecker RE, Thakkar MM, McCarley RW. Adenosine and sleep-wake regulation. Prog. Neurobiol. 2004;73:379–396. [PubMed] [Google Scholar]
9. Belfrage M, Segerdahl M, Arnér S, Sollevi A. The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain. Anesth. Analg. 1999;89:136–142. [PubMed] [Google Scholar]
10. Belfrage M, Sollevi A, Segerdahl M, Sjölund KF, Hansson P. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth. Analg. 1995;81:713–717. [PubMed] [Google Scholar]
11. Berman RF, Fredholm BB, Aden U, O'Connor WT. Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats. Brain Res. 2000;872:44–53. [PubMed] [Google Scholar]
12. Bishnoi M, Chopra K, Kulkarni SK. Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes. Pharmacology. 2007;79:171–183. [PubMed] [Google Scholar]
13. Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 2003;85:267–273. [PubMed] [Google Scholar]
14. Blum D, Gall D, Galas MC, d'Alcantara P, Bantubungi K, Schiffmann SN. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity. J. Neurosci. 2002;22:9122–9133. [PMC free article] [PubMed] [Google Scholar]
15. Bodenant M, Moreau C, Sejourné C, Auvin S, Delval A, Cuisset JM, Derambure P, Destée A, Defebvre L. Interest of the ketogenic diet in a refractory status epilepticus in adults. Rev. Neurol. (Paris) 2008;164:194–199. [PubMed] [Google Scholar]
16. Boison D. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. Neurodegener. Dis. 2007;4:28–33. [PubMed] [Google Scholar]
17. Boison D. Adenosine as a neuromodulator in neurological diseases. Curr. Opin. Pharmacol. 2008;8:2–7. [PMC free article] [PubMed] [Google Scholar]
18. Boison D. The adenosine kinase hypothesis of epileptogenesis. Prog. Neurobiol. 2008;84:249–262. [PMC free article] [PubMed] [Google Scholar]
19. Bottini N, De Luca D, Saccucci P, Fiumara A, Elia M, Porfirio MC, Lucarelli P, Curatolo P. Autism: evidence of association with adenosine deaminase genetic polymorphism. Neurogenetics. 2001;3:111–113. [PubMed] [Google Scholar]
20. Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, Shaw R, Smith Y, Geiger JD, Dingledine RJ. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 2006;60:223–235. [PubMed] [Google Scholar]
21. Brambilla D, Chapman D, Greene R. Adenosine mediation of presynaptic feedback inhibition of glutamate release. Neuron. 2005;46:275–283. [PubMed] [Google Scholar]
22. Calabresi P, Centonze D, Pisani A, Bernardi G. Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses. J. Neurosci. 1997;17:4509–4516. [PMC free article] [PubMed] [Google Scholar]
23. Caruso CC. Possible broad impacts of long work hours. Ind. Health. 2009;44:531–536. [PubMed] [Google Scholar]
24. Chalfant AM, Rapee R, Carroll L. Treating anxiety disorders in children with high functioning autism spectrum disorders: a controlled trial. J. Autism Dev. Disord. 2007;37:1842–1857. [PubMed] [Google Scholar]
25. Chen F, Lemonnier E, Lazartigues A, Planche P. Sleep problems and information processing, a "disconnection effect" in autism? Med. Hypotheses. 2006;66:1245–1246. [PubMed] [Google Scholar]
26. Chez MG, Chang M, Krasne V, Coughlan C, Kominsky M, Schwartz A. Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav. 2006;8:267–271. [PubMed] [Google Scholar]
27. Cullingford TE, Dolphin CT, Sato H. The peroxisome proliferator-activated receptor α-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain. Neuropharmacology. 2002;42:724–730. [PubMed] [Google Scholar]
28. Cullingford TE, Eagles DA, Sato H. The ketogenic diet upregulates expression of the gene encoding the key ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in rat brain. Epilepsy Res. 2002;49:99–107. [PubMed] [Google Scholar]
29. Cunha RA. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 2001;38:107–125. [PubMed] [Google Scholar]
30. Curran LK, Newschaffer CJ, Lee LC, Crawford SO, Johnston MV, Zimmerman AW. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics. 2007;120:e1386–e1392. [PubMed] [Google Scholar]
31. Curros-Criado MM, Herrero JF. The antinociceptive effects of the systemic adenosine A1 receptor agonist CPA in the absence and in the presence of spinal cord sensitization. Pharmacol. Biochem. Behav. 2005;82:721–726. [PubMed] [Google Scholar]
32. Cuzzocrea S, Mazzon E, Dugo L, Patel NS, Serraino I, Di Paolo R, Genovese T, Britti D, De Maio M, Caputi AP, Thiemermann C. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Arthritis Rheum. 2003;48:3544–3556. [PubMed] [Google Scholar]
33. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel NS, Di Paola R, Ialenti A, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. Eur. J. Pharmacol. 2004;483:79–93. [PubMed] [Google Scholar]
34. Dale N, Pearson T, Frenguelli BG. Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J. Physiol. 2000;526:143–155. [PMC free article] [PubMed] [Google Scholar]
35. Davis LM, Pauly JR, Readnower RD, Rho JM, Sullivan PG. Fasting is neuroprotective following traumatic brain injury. J. Neurosci. Res. 2008;86:1812–1822. [PubMed] [Google Scholar]
36. de Mendonça A, Almeida T, Bashir ZI, Ribeiro JA. Endogenous adenosine attenuates long-term depression and depotentiation in the CA1 region of the rat hippocampus. Neuropharmacology. 1997;36:161–167. [PubMed] [Google Scholar]
37. DeVivo DC, Leckie MP, Ferrendelli JS, McDougal DB Jr. Chronic ketosis and cerebral metabolism. Ann. Neurol. 1978;3:331–337. [PubMed] [Google Scholar]
38. DiMario FJ Jr, Holland J. The ketogenic diet: a review of the experience at Connecticut Children's Medical Center. Pediatr. Neurol. 2002;26:288–292. [PubMed] [Google Scholar]
39. Dionyssopoulos T, Hope W, Coupar IM. Effect of adenosine analogues on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 1992;42:201–206. [PubMed] [Google Scholar]
40. Doolette DJ. Mechanism of adenosine accumulation in the hippocampal slice during energy deprivation. Neurochem. Int. 1997;30:211–223. [PubMed] [Google Scholar]
41. Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc. Natl. Acad. Sci. USA. 2003;100:2911–2916. [PMC free article] [PubMed] [Google Scholar]
42. Dulla CG, Dobelis P, Pearson T, Frenguelli BG, Staley KJ, Masino SA. Adenosine and ATP link PCO2 to cortical excitability via pH. Neuron. 2005;48:1011–1023. [PMC free article] [PubMed] [Google Scholar]
43. Dunwiddie TV. Adenosine and suppression of seizures. Adv. Neurol. 1999;79:1001–1010. [PubMed] [Google Scholar]
44. Dunwiddie TV, Diao LH, Proctor WR. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J. Neurosci. 1997;17:7673–7682. [PMC free article] [PubMed] [Google Scholar]
45. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 2001;24:31–55. [PubMed] [Google Scholar]
46. During MJ, Spencer DD. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 1993;32:618–624. [PubMed] [Google Scholar]
47. Dworak M, Diel P, Voss S, Hollmann W, Strüder HK. Intense exercise increases adenosine concentrations in rat brain: implications for a homeostatic sleep drive. Neuroscience. 2007;150:789–795. [PubMed] [Google Scholar]
48. Eagles DA, Chapman GB. A light- and electron-microscope study of hepatocytes of rats fed different diets. C. R. Biol. 2007;330:62–70. [PubMed] [Google Scholar]
49. Edelson SM, Edelson MG, Kerr DC, Grandin T. Behavioral and physiological effects of deep pressure on children with autism: a pilot study evaluating the efficacy of Grandin's Hug Machine. Am. J. Occup. Ther. 1999;53:145–152. [PubMed] [Google Scholar]
50. Eisenach JC, Rauck RL, Curry R. Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. Pain. 2003;105:65–70. [PubMed] [Google Scholar]
51. Elzein E, Zablocki J. A1 adenosine receptor agonists and their potential therapeutic applications. Expert Opin. Investig. Drugs. 2008;17:1901–1910. [PubMed] [Google Scholar]
52. Etherington LA, Patterson GE, Meechan L, Boison D, Irving AJ, Dale N, Frenguelli B. Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus. Neuropharmacology. 2008;56:429–437. [PMC free article] [PubMed] [Google Scholar]
53. Evangeliou A, Vlachonikolis I, Mihailidou H, Spilioti M, Skarpalezou A, Makaronas N, Prokopiou A, Christodoulou P, Liapi-Adamidou G, Helidonis E, Sbyrakis S, Smeitink J. Application of a ketogenic diet in children with autistic behavior: pilot study. J. Child Neurol. 2003;18:113–118. [PubMed] [Google Scholar]
54. Ferré S, Agnati LF, Ciruela F, Lluis C, Woods AS, f*cke K, Franco R. Neurotransmitter receptor heteromers and their integrative role in 'local modules': The striatal spine module. Brain Res. Rev. 2007;55:55–67. [PMC free article] [PubMed] [Google Scholar]
55. Fowler JC. Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hippocampal brain slice. Brain Res. 1989;490:378–384. [PubMed] [Google Scholar]
56. Fowler JC. Adenosine antagonists alter the synaptic response to in vitro ischemia in the rat hippocampus. Brain Res. 1990;509:331–334. [PubMed] [Google Scholar]
57. Fowler JC. Purine release and inhibition of synaptic transmission during hypoxia and hypoglycemia in rat hippocampal slices. Neurosci. Lett. 1993;157:83–86. [PubMed] [Google Scholar]
58. Fredholm BB. Purinoceptors in the nervous system. Pharmacol. Toxicol. 1995;76:228–239. [PubMed] [Google Scholar]
59. Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007;14:1315–1323. [PubMed] [Google Scholar]
60. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 1999;51:83–133. [PubMed] [Google Scholar]
61. Fredholm BB, Jonzon B, Lindstrom K. Adenosine receptor mediated increases and decreases in cyclic AMP in hippocampal slices treated with forskolin. Acta Physiol. Scand. 1983;117:461–463. [PubMed] [Google Scholar]
62. Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics. 1998;102:1358–1363. [PubMed] [Google Scholar]
63. Frenguelli BG, Llaudet E, Dale N. High-resolution real-time recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices. J. Neurochem. 2003;86:1506–1515. [PubMed] [Google Scholar]
64. Frenguelli BG, Wigmore G, Llaudet E, Dale N. Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J. Neurochem. 2007;101:1400–1413. [PMC free article] [PubMed] [Google Scholar]
65. f*ckao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid metabolism. Prostaglandins Leukot. Essent. Fatty Acids. 2004;70:243–251. [PubMed] [Google Scholar]
66. f*cke K, Ferré S, Genedani S, Franco R, Agnati LF. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol. Behav. 2007;92:210–217. [PubMed] [Google Scholar]
67. Gabriel A, Klussmann FW, Igelmund P. Rapid temperature changes induce adenosine-mediated depression of synaptic transmission in hippocampal slices from rats (non-hibernators) but not in slices from golden hamsters (hibernators) Neuroscience. 1998;86:67–77. [PubMed] [Google Scholar]
68. Gallos G, Ruyle TD, Emala CW, Lee HT. A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis. Am. J. Physiol. Renal Physiol. 2005;289:F369–F376. [PubMed] [Google Scholar]
69. Garriga-Canut M, Schoenike B, Qazi R, Bergendahl K, Daley TJ, Pfender RM, Morrison JF, Ockuly J, Stafstrom C, Sutula T, Roopra A. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 2006;9:1382–1387. [PubMed] [Google Scholar]
70. Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav. Pharmacol. 2006;17:431–439. [PMC free article] [PubMed] [Google Scholar]
71. Gianfriddo M, Corsi C, Melani A, Pèzzola A, Reggio R, Popoli P, Pedata F. Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease. Brain Res. 2003;979:225–229. [PubMed] [Google Scholar]
72. Godbout R, Bergeron C, Limoges E, Stip E, Mottron L. A laboratory study of sleep in Asperger's syndrome. Neuroreport. 2000;11:127–130. [PubMed] [Google Scholar]
73. Goodman RR, Snyder SH. Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine. J. Neurosci. 1982;2:1230–1241. [PMC free article] [PubMed] [Google Scholar]
74. Gouder N, Fritschy J-M, Boison D. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia. 2003;44:877–885. [PubMed] [Google Scholar]
75. Gouder N, Scheurer L, Fritschy JM, Boison D. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J. Neurosci. 2004;24:692–701. [PMC free article] [PubMed] [Google Scholar]
76. Gourine A, Bondar SI, Spyer KM, Gourine AV. Release of ATP and glutamate in the nucleus tractus solitarii mediate pulmonary stretch receptor (Breuer-Hering) reflex pathway. J. Physiol. 2008;586:3963–3978. [PMC free article] [PubMed] [Google Scholar]
77. Gourine AV, Llaudet E, Dale N, Spyer KM. ATP is a mediator of chemosensory transduction in the central nervous system. Nature. 2005;436:108–111. [PubMed] [Google Scholar]
78. Grandin T, Scariano MM. Emergence: Labeled Autistic. New York: Warner Books; 1996. [Google Scholar]
79. Guieu R, Couraud F, Pouget J, Sampieri F, Bechis G, Rochat H. Adenosine and the nervous system: clinical implications. Clin. Neuropharmacol. 1996;19:459–474. [PubMed] [Google Scholar]
80. Haas RH, Rice MA, Tauner DA, Merritt TA. Therapeutic effects of a ketogenic diet in Rett syndrome. Am. J. Med. Genet. Suppl. 1986;1:225–246. [PubMed] [Google Scholar]
81. Haces ML, Hernández-Fonseca K, Medina-Campos ON, Montiel T, Pedraza-Chaverri J, Massieu L. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp. Neurol. 2008;211:85–96. [PubMed] [Google Scholar]
82. Halassa MM, Florian C, Fellin T, Munoz JR, Lee SY, Abel T, Haydon PG, Frank MG. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron. 2009;61:213–219. [PMC free article] [PubMed] [Google Scholar]
83. Hallböök T, Lundgren J, Rosén I. Ketogenic diet improves sleep quality in children with therapy-resistant epilepsy. Epilepsia. 2007;48:59–65. [PubMed] [Google Scholar]
84. Herrero Matteo LM, Ros Die E, Sanchez Fernandes-Bravo J. [Changes in the muscular pH and other parameters of tissue hypoxia during prolonged and intense exercise] Angiologia. 1977;29:118–134. [PubMed] [Google Scholar]
85. Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit. Rev. Food Sci. Nutr. 2006;46:101–123. [PubMed] [Google Scholar]
86. Hill CM, Hogan AM, Karmiloff-Smith A. To sleep, perchance to enrich learning? Arch. Dis. Child. 2007;92:637–643. [PMC free article] [PubMed] [Google Scholar]
87. Hornig M, Lipkin WI. Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses, and animal models. Ment. Retard. Dev. Disabil. Res. Rev. 2001;7:200–210. [PubMed] [Google Scholar]
88. Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, Fredholm BB, Urade Y, Hayaishi O. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat. Neurosci. 2005;8:858–859. [PubMed] [Google Scholar]
89. Huber A, Padrun V, Déglon N, Aebischer P, Möhler H, Boison D. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc. Natl. Acad. Sci. USA. 2001;98:7611–7616. [PMC free article] [PubMed] [Google Scholar]
90. Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Giménez-Llort L, Escorihuela LM, Fernéndez-Teruel A, Wiesenfeld-Hallin Z, Xu XJ, Hårdemark A, Betscholtz C, Herlenius E, Fredholm BB. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. USA. 2001;98:9407–9412. [PMC free article] [PubMed] [Google Scholar]
91. Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 2001;120:170–179. [PubMed] [Google Scholar]
92. Kafka SH, Corbett R. Selective adenosine A 2A receptor dopamine D 2 receptor interactions in animal models of schizophrenia. Eur. J. Pharmacol. 1996;295:147–154. [PubMed] [Google Scholar]
93. Kaku T, Jiang MH, Hada J, Morimoto K, Hayashi Y. Sodium nitroprusside-induced seizures and adenosine release in rat hippocampus. Eur. J. Pharmacol. 2001;413:199–205. [PubMed] [Google Scholar]
94. Kalinchuk AV, McCarley RW, Stenberg D, Porkka-Heiskanen T, Basheer R. The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions. Neuroscience. 2008;157:238–253. [PMC free article] [PubMed] [Google Scholar]
95. Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV. Control of glucose utilization in working perfused rat heart. J. Biol. Chem. 1994;269:25502–25514. [PubMed] [Google Scholar]
96. Kawamura M, Jr., Masino SA. Purinergic autocrine regulation of CA3 pyramidal neurons: activation of adenosine A1 receptors in the rat hippocampus. Soc. Neurosci. Abstr. 2008;825:26. [Google Scholar]
97. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature. 1979;277:93–96. [PubMed] [Google Scholar]
98. Kern L, Koegel RL, Dunlap G. The influence of vigorous versus mild exercise on autistic stereotyped behaviors. J. Autism Dev. Disord. 1984;14:57–67. [PubMed] [Google Scholar]
99. Kim D, Rho J. Ketone bodies potect against impairment of synaptic transmission in rat hippocampal slices by mitochondrial respiratory inhibitors. Soc. Neurosci. Abstr. 2007;786:713. [Google Scholar]
100. Klotz KN. Adenosine receptors and their ligands. Naunyn-Schmeidebergs Arch. Pharmacol. 2000;362:382–391. [PubMed] [Google Scholar]
101. Knapp CM, Foye MM, Cottam N, Ciraulo DA, Kornetsky C. Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration. Pharmacol. Biochem. Behav. 2001;68:797–803. [PubMed] [Google Scholar]
102. Korde AS, Pettigrew LC, Craddock SD, Maragos WF. The mitochondrial uncoupler 2,4-dinitrophenol attenuates tissue damage and improves mitochondrial homeostasis following transient focal cerebral ischemia. J. Neurochem. 2005;94:1676–1684. [PubMed] [Google Scholar]
103. Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia. 2008;49(Suppl 8):37–41. [PubMed] [Google Scholar]
104. Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003;61:1789–1791. [PubMed] [Google Scholar]
105. Kotagal P, Yardi N. The relationship between sleep and epilepsy. Semin. Pediatr. Neurol. 2008;15:42–49. [PubMed] [Google Scholar]
106. Kwan RM, Thomas S, Mir MA. Effects of a low carbohydrate isoenergetic diet on sleep behavior and pulmonary functions in healthy female adult humans. J. Nutr. 1986;116:2393–2402. [PubMed] [Google Scholar]
107. Lara DR, Brunstein MG, Ghisolfi ES, Lobato MI, Bel-monte-de-Abreu P, Souza DO. Allopurinol augmentation for poorly responsive schizophrenia. Int. Clin. Psychopharmacol. 2001;16:235–237. [PubMed] [Google Scholar]
108. Latini S, Corsi C, Pedata F, Pepeu G. The source of brain adenosine outflow during ischemia and electrical stimulation. Neurochem. Int. 1995;27:239–244. [PubMed] [Google Scholar]
109. Latini S, Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 2001;79:463–484. [PubMed] [Google Scholar]
110. Lee HT, Xu H, Nasr SH, Schnermann J, Emala CW. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am. J. Physiol. Renal Physiol. 2004;286:F298–F306. [PubMed] [Google Scholar]
111. Lee J, Bruce-Keller AJ, Kruman Y, Chan SL, Mattson MP. 2-Deoxy-D-glucose protects hippocampal neurons against excitotoxic and oxidative injury: evidence for the involvement of stress proteins. J. Neurosci. Res. 1999;57:48–61. [PubMed] [Google Scholar]
112. Lee Y-W, Yaksh TL. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J. Pharmacol. Exp. Ther. 1996;277:1642–1648. [PubMed] [Google Scholar]
113. Listos J, Talarek S, Fidecka S. Involvement of adenosine receptor agonists on the development of hypersensitivity to acute dose of morphine during morphine withdrawal period. Pharmacol. Rep. 2008;60:679–685. [PubMed] [Google Scholar]
114. Lloyd HG, Lindström K, Fredholm BB. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem. Int. 1993;23:173–185. [PubMed] [Google Scholar]
115. LoVerme J, Fu J, Astarita G, La Rana G, Russo R, Calig-nano A, Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 2005;67:15–19. [PubMed] [Google Scholar]
116. Ma TC, Buescher JL, Oatis B, Funk JA, Nash AJ, Carrier RL, Hoyt KR. Metformin therapy in a transgenic mouse model of Huntington's disease. Neurosci. Lett. 2007;411:98–103. [PubMed] [Google Scholar]
117. Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 2007;145:256–264. [PMC free article] [PubMed] [Google Scholar]
118. Malow BA. Sleep disorders, epilepsy, and autism. Ment. Retard. Dev. Disabil. Res. Rev. 2004;10:122–125. [PubMed] [Google Scholar]
119. Manzoni OJ, Manabe T, Nicoll RA. Release of adenosine by activation of NMDA receptors in the hippocampus. Science. 1994;265:2098–2101. [PubMed] [Google Scholar]
120. Marie S, Race V, Nassogne MC, Vincent MF, Van den Berghe G. Mutation of a nuclear respiratory factor 2 binding site in the 5' untranslated region of the ADSL gene in three patients with adenylosuccinate lyase deficiency. Am. J. Hum. Genet. 2002;71:14–21. [PMC free article] [PubMed] [Google Scholar]
121. Marsh J, Mukherjee P, Seyfried TN. Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet. Nutr. Metab. (Lond.) 2008;5:33. [PMC free article] [PubMed] [Google Scholar]
122. Martin B, Golden E, Carlson OD, Pistell P, Zhou J, Kim W, Frank BP, Thomas S, Chadwick WA, Greig NH, Bates GP, Sathasivam K, Bernier M, Maudsley S, Mattson MP, Egan JM. Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease. Diabetes. 2009;58:318–328. [PMC free article] [PubMed] [Google Scholar]
123. Martín ED, Fernández M, Perea G, Pascual O, Haydon PG, Araque A, Ceña V. Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission. Glia. 2007;55:36–45. [PubMed] [Google Scholar]
124. Masino SA, Dunwiddie TV. Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine. J. Neurosci. 1999;19:1932–1939. [PMC free article] [PubMed] [Google Scholar]
125. Masino SA, Geiger JD. Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci. 2008;31:273–278. [PMC free article] [PubMed] [Google Scholar]
126. Masino SA, Geiger JD. The ketogenic diet and epilepsy: Is adenosine the missing link? Epilepsia. 2009;50:332–333. [PubMed] [Google Scholar]
127. Masino SA, Gockel JA, Wasser CA, Pomeroy LT, Wagener JF, Gawryluk JW, Geiger JD. The relationship among ATP, adenosine and a ketogenic diet. Soc. Neurosci. Abstr. 2007;595:512. [Google Scholar]
128. Masino SA, Latini S, Bordoni F, Pedata F, Dunwiddie TV. Changes in hippocampal adenosine efflux, ATP levels, and synaptic transmission induced by increased temperature. Synapse. 2001;41:58–64. [PMC free article] [PubMed] [Google Scholar]
129. Masino SA, Mesches MH, Bickford PC, Dunwiddie TV. Acute peroxide treatment of rat hippocampal slices induced adenosine-mediated inhibition of excitatory transmission in area CA1. Neurosci. Lett. 1999;274:91–94. [PubMed] [Google Scholar]
130. Melani A, Corsi C, Giménez-Llort L, Martínez E, Ogren SO, Pedata F, Ferré S. Effect of N-methyl-D-aspartate on motor activity and in vivo adenosine striatal outflow in the rat. Eur. J. Pharmacol. 1999;385:15–19. [PubMed] [Google Scholar]
131. Minor TR, Rowe MK, Soames Job RF, Ferguson EC. Escape deficits induced by inescapable shock and metabolic stress are reversed by adenosine receptor antagonists. Behav. Brain Res. 2001;120:203–212. [PubMed] [Google Scholar]
132. Mitchell JB, Lupica CR, Dunwiddie TV. Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J. Neurosci. 1993;13:3439–3447. [PMC free article] [PubMed] [Google Scholar]
133. Murillo-Rodriguez E, Liu M, Blanco-Centurion C, Shiromani PJ. Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain. Eur. J. Neurosci. 2008;28:1191–1198. [PMC free article] [PubMed] [Google Scholar]
134. Nakazawa M, Kodama S, Matsuo T. Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides. Brain Dev. 1983;5:375–380. [PubMed] [Google Scholar]
135. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7:500–506. [PubMed] [Google Scholar]
136. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Brain Res. Rev. 1992;17:139–170. [PubMed] [Google Scholar]
137. Nemeth PM, Rosser BW, Choksi RM, Norris BJ, Baker KM. Metabolic response to a high-fat diet in neonatal and adult rat muscle. Am. J. Physiol. Cell Physiol. 1992;262:C282–C286. [PubMed] [Google Scholar]
138. Newby AC. Adenosine and the concept of "retaliatory metabolites". Trends Biochem. Sci. 1984;9:42–44. [Google Scholar]
139. Newcomer JW. Metabolic risk during antipsychotic treatment. Clin. Ther. 2004;26:1936–1946. [PubMed] [Google Scholar]
140. Niglio T, Popoli P, Caporali MG, Scotti de Carolis A. Antiepileptic effects of N6-L-phenylisopropyladenosine (L-PIA) on penicillin-induced epileptogenic focus in rabbits. Pharmacol. Res. Commun. 1988;20:561–572. [PubMed] [Google Scholar]
141. Noh HS, Lee HP, Kim DW, Kang SS, Cho GJ, Rho JM, Choi WS. A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Mol. Brain Res. 2004;129:80–87. [PubMed] [Google Scholar]
142. Nyhan WL, James JA, Teberg AJ, Sweetman L, Nelson LG. A new disorder of purine metabolism with behavioral manifestations. J. Pediatr. 1969;74:20–27. [PubMed] [Google Scholar]
143. Nylen K, Velazquez JL, Sayed V, Gibson KM, Burnham WM, Snead O.C 3rd. The effects of a ketogenic diet on ATP concentrations and the number of hippocampal mitochondria in Aldh5a1(-/-) mice. Biochim. Biophys. Acta. 2009 in press. [PMC free article] [PubMed] [Google Scholar]
144. O'Neill MF. Study focuses in on potential cause of antipsychotic-induced diabetes. Drug News Perspect. 2005;18:481–482. [PubMed] [Google Scholar]
145. Orford MR, Saggerson ED. A low-Km 5'-nucleotidase from rat brain cytosolic fraction: purification, kinetic properties, and description of regulation by a novel factor that increases sensitivity to inhibition by ATP and ADP. J. Neurochem. 1996;67:795–804. [PubMed] [Google Scholar]
146. Otsuguro K, Yamaji Y, Ban M, Ohta T, Ito S. Involvement of adenosine in depression of synaptic transmission during hypercapnia in isolated spinal cord of neonatal rats. J. Physiol. 2006;574:835–847. [PMC free article] [PubMed] [Google Scholar]
147. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J. Clin. Invest. 1967;46:1589–1595. [PMC free article] [PubMed] [Google Scholar]
148. Pacheco A, Easterling WS, Pryer MW. A pilot study of the ketogenic diet in schizophrenia. Am. J. Psychiatry. 1965;121:1110–1111. [PubMed] [Google Scholar]
149. Page T, Coleman M. Purine metabolism abnormalities in a hyperuricosuric subclass of autism. Biochim. Biophys. Acta. 2000;1500:291–296. [PubMed] [Google Scholar]
150. Page T, Moseley C. Metabolic treatment of hyperuricosuric autism. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2002;26:397–400. [PubMed] [Google Scholar]
151. Pan JW, Bebin EM, Chu WJ, Hetherington HP. Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T. Epilepsia. 1999;40:703–707. [PubMed] [Google Scholar]
152. Pandya JD, Pauly JR, Nukala VN, Sebastian AH, Day KM, Korde AS, Maragos WF, Hall ED, Sullivan PG. Post-injury administration of mitochondrial uncouplers increases tissue sparing and improves behavioral outcome following traumatic brain injury in rodents. J. Neurotrauma. 2007;24:798–811. [PubMed] [Google Scholar]
153. Panico LR, Ríos VG, Demartini MG, Carniello MA. [The electroencephalographic evolution of a group of patients on a ketonic diet] Rev. Neurol. 2000;30:8–15. [PubMed] [Google Scholar]
154. Parkinson FE, Xiong W. Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons. J. Neurochem. 2004;88:1305–1312. [PubMed] [Google Scholar]
155. Parkinson FE, Xiong W, Zamzow CR. Astrocytes and neurons: different roles in regulating adenosine levels. Neurol. Res. 2005;27:153–160. [PubMed] [Google Scholar]
156. Pascual O, Casper KB, Kubera C, Zhang J, Revilla-Sanchez R, Sul JY, Takano H, Moss SJ, McCarthy K, Haydon PG. Astrocytic purinergic signaling coordinates synaptic networks. Science. 2005;310:113–116. [PubMed] [Google Scholar]
157. Pedata F, Pazzagli M, Tilli S, Pepeu G. Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices. Naunyn Schmeidebergs Arch. Pharmacol. 1990;342:447–453. [PubMed] [Google Scholar]
158. Peters SJ, St. Amand TA, Howlett RA, Heigenhauser GJF, Spriet LL. Human skeletal muscle pyruvate dehydrogenase kinase activity increases after a low-carbohydrate diet. Am. J. Physiol. Endocrinol. Metab. 1998;275:E980–E986. [PubMed] [Google Scholar]
159. Phillips F, Chen CN, Crisp AH, Koval J, McGuinness B, Kalucy RS, Kalucy EC, Lacey JH. Isocaloric diet changes and electroencephalographic sleep. Lancet. 1975;2:723–725. [PubMed] [Google Scholar]
160. Plunet WT, Streijger F, Lam CK, Lee JH, Liu J, Tetzlaff W. Dietary restriction started after spinal cord injury improves functional recovery. Exp. Neurol. 2008;213:28–35. [PubMed] [Google Scholar]
161. Porkka-Heiskanen T, Strecker RE, McCarley RW. Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience. 2000;99:507–517. [PubMed] [Google Scholar]
162. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, McCarley RW. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science. 1997;276:1265–1268. [PMC free article] [PubMed] [Google Scholar]
163. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 1990;43:273–286. [PubMed] [Google Scholar]
164. Qin P, Xu H, Laursen TM, Vestergaard M, Mortensen PB. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ. 2005;331:23. [PMC free article] [PubMed] [Google Scholar]
165. Radulovacki M, Miletich RS, Green RD. N6 (L-phenylisopropyl) adenosine (L-PHA) increases slow-wave sleep (S2) and decreases wakefulness in rats. Brain Res. 1982;246:178–180. [PubMed] [Google Scholar]
166. Rainnie DG, Grunze HC, McCarley RW, Greene RW. Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science. 1994;263:689–692. [PMC free article] [PubMed] [Google Scholar]
167. Rho JM, Sarnat HB, Sullivan PG, Robbins CA, Kim DW. Lack of long-term histopathologic changes in brain and skeletal muscle of mice treated with a ketogenic diet. J. Child Neurol. 2004;19:555–557. [PubMed] [Google Scholar]
168. Rogawski MA. Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res. 2006;69:273–294. [PMC free article] [PubMed] [Google Scholar]
169. Rosin DL, Hettinger BD, Lee A, Linden J. Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function. Neurology. 2003;61:S12–18. [PubMed] [Google Scholar]
170. Sala-Newby GB, Skladanowski AC, Newby AC. The mechanism of adenosine formation in cells. Cloning of cytosolic 5'-nucleotidase-I. J. Biol. Chem. 1999;274:17789–17793. [PubMed] [Google Scholar]
171. Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP. Kidney stones and the ketogenic diet: risk factors and prevention. J. Child. Neurol. 2007;22:375–378. [PubMed] [Google Scholar]
172. Saransaari P, Oja SS. Enhanced release of adenosine under cell-damaging conditions in the developing and adult mouse hippocampus. Neurochem. Res. 2003;28:1409–1417. [PubMed] [Google Scholar]
173. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, Chance B, Clarke K, Veech RL. Insulin, ketone bodies, and mitochondrial energy transfer. FASEB J. 1995;9:651–658. [PubMed] [Google Scholar]
174. Satoh S, Matsumura H, Suzuki F, Hayaishi O. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. Proc. Natl. Acad. Sci. USA. 1996;93:5980–5984. [PMC free article] [PubMed] [Google Scholar]
175. Schubert P. Physiological modulation by adenosine: selective blockade of A1-receptors with DPCPX enhances stimulus train-evoked neuronal Ca influx in rat hippocampal slices. Brain Res. 1988;458:162–165. [PubMed] [Google Scholar]
176. Semba K, White TD. M3 muscarinic receptor-mediated enhancement of NMDA-evoked adenosine release in rat cortical slices in vitro. J. Neurochem. 1997;69:1066–1072. [PubMed] [Google Scholar]
177. Seyfried TN, Mukherjee P. Targeting energy metabolism in brain cancer: review and hypothesis. Nutr. Metab. 2005;2:30. [PMC free article] [PubMed] [Google Scholar]
178. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J. Am. Acad. Child Adolesc. Psychiatry. 2008;47:921–929. [PubMed] [Google Scholar]
179. Smith M, Hopkins D, Peveler RC, Holt RI, Woodward M, Ismail K. First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br. J. Psychiatry. 2008;192:406–411. [PubMed] [Google Scholar]
180. Sollevi A. Adenosine for pain control. Acta Anaesthesiol. Scand. Suppl. 1997;110:135–136. [PubMed] [Google Scholar]
181. Stafstrom CE, Roopra A, Sutula TP. Seizure suppression via glycolysis inhibition with 2-deoxy-D-glucose (2DG) Epilepsia. 2008;49(Suppl 8):97–100. [PubMed] [Google Scholar]
182. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 2004;55:576–580. [PubMed] [Google Scholar]
183. Sun C-X, Young HW, Molina JG, Volmer JB, Schnermann J, Blackburn MR. A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J. Clin. Invest. 2005;115:35–43. [PMC free article] [PubMed] [Google Scholar]
184. Tierney E, Nworoko NA, Kelley RI. Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 2000;6:131–134. [PubMed] [Google Scholar]
185. Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, Warren K, Power C. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J. Neurosci. 2004;24:1521–1529. [PMC free article] [PubMed] [Google Scholar]
186. Varma H, Cheng R, Voisine C, Hart AC, Stockwell BR. Inhibitors of metabolism rescue cell death in Huntington's disease models. Proc. Natl. Acad. Sci. USA. 2007;104:14525–14530. [PMC free article] [PubMed] [Google Scholar]
187. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids. 2004;70:309–319. [PubMed] [Google Scholar]
188. Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, Camfield PR, Holmes GL, Shinnar S, Shuman R, Trevathan E, Wheless JW. A multicenter study of the efficacy of the ketogenic diet. Arch. Neurol. 1998;55:1433–1437. [PubMed] [Google Scholar]
189. Virus RM, Ticho S, Pilditch M, Radulovacki M. A comparison of the effects of caffeine, 8-cyclopentyltheophylline, and alloxazine on sleep in rats. Possible roles of central nervous system adenosine receptors. Neuropsychopharmacology. 1990;3:243–249. [PubMed] [Google Scholar]
190. Von Lubitz DKJE, Beenhakker M, Lin RC, Carter MF, Paul IA, Bischofberger N, Jacobson KA. Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist. Eur. J. Pharmacol. 1996;302:43–48. [PMC free article] [PubMed] [Google Scholar]
191. Weerts EM, Griffiths RR. The adenosine receptor antagonist CGS15943 reinstates cocaine-seeking behavior and maintains self-administration in baboons. Psychopharmacology. 2003;168:155–163. [PubMed] [Google Scholar]
192. Westman EC, Yancy WS, Jr., Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr. Metab. (Lond.) 2008;5:36. [PMC free article] [PubMed] [Google Scholar]
193. Whitcomb K, Lupica CR, Rosen JB, Berman RF. Adenosine involvement in postictal events in amygdala-kindled rats. Epilepsy Res. 1990;6:171–179. [PubMed] [Google Scholar]
194. Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clin. Proc. 1921;2:307–308. [Google Scholar]
195. Wong V. Epilepsy in children with autistic spectrum disorder. J. Child Neurol. 1993;8:316–322. [PubMed] [Google Scholar]
196. Wu W-P, Hao J-X, Halldner L, Lovdahl C, DeLander GE, Wiesenfeld-Hallin Z, Fredholm BB, Xu X-J. Increased nociceptive response in mice lacking the adenosine A1 receptor. Pain. 2005;113:395–404. [PubMed] [Google Scholar]
197. Xu K, Bastia E, Schwarzschild M. Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease. Pharmacol. Ther. 2005;105:267–310. [PubMed] [Google Scholar]
198. Yancy WS, Jr., Foy M, Chalecki AM, Vernon MC, Westman EC. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr. Metab. (Lond.) 2005;2:34. [PMC free article] [PubMed] [Google Scholar]
199. Zhang J-M, Wang H-K, Ye C-Q, Ge W, Chen Y, Jiang Z-l, Wu C-P, Poo M-M, Duan S. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron. 2003;40:971–982. [PubMed] [Google Scholar]
200. Zhao YT, Tekkök S, Krnjevic K. 2-Deoxy-D-glucose-induced changes in membrane potential, input resistance, and excitatory postsynaptic potentials of CA1 hippocampal neurons. Can. J. Physiol. Pharmacol. 1997;75:368–374. [PubMed] [Google Scholar]
201. Zhu PJ, Krnjevic K. Adenosine release is a major cause of failure of synaptic transmission during hypoglycaemia in rat hippocampal slices. Neurosci. Lett. 1993;155:128–131. [PubMed] [Google Scholar]
202. Zhu PJ, Krnjevic K. Adenosine release mediates cyanide-induced suppression of CA1 neuronal activity. J. Neurosci. 1997;17:2355–2364. [PMC free article] [PubMed] [Google Scholar]
203. Ziegler DR, Gamaro GD, Araújo E, Bassani MG, Perry MLS, Dalmaz C, Gonçalves C-A. Nociception and locomotor activity are increased in ketogenic diet fed rats. Physiol. Behav. 2005;84:421–427. [PubMed] [Google Scholar]
